Records containing: Platelet Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-12ATHN Transcends: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment in People With Non-Neoplastic Hematologic Disorders
-
CLINICAL_TRIALS study record update · 2024-11-15Multicenter Observational Ambispective Study for Congenital Platelet Disorders
-
CLINICAL_TRIALS study record update · 2024-10-08Rifaximin Blunted Higher Levels of Endotoxin in Cirrhosis Patients: a Randomized, Double Blind, Short Term Interventional Trial
-
CLINICAL_TRIALS study record update · 2023-12-04Towards Improved Diagnostics for Suspected Platelet Function Disorders
-
CLINICAL_TRIALS study record update · 2023-02-10PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-12-23Study on Avatrombopag for the Promotion of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2021-12-09A Phase II Trial of Avatrombopag for the Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2019-06-11Safety and Efficacy of Eltrombopag at Escalated Doses up to 150mg in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) Not Responsive to 75 mg
-
CLINICAL_TRIALS study record update · 2018-03-29Influence of Cardiopulmonary Bypass on Platelet Function in Patients With Preoperative Dual Antiplatelet Therapy: